Discovery of Immune Signatures

About IMU Biosciences

IMU Biosciences is an early-stage biotech leveraging AI and multi-omics to map the immune system at unprecedented scale and resolution. Its proprietary platform, built on research from King's College London and the Francis Crick Institute, analyzes vast immune datasets to discover novel signatures for drug development and precision medicine applications. The company is positioned as a platform and discovery partner for pharmaceutical companies, aiming to increase R&D success and enable immune-driven diagnostics and therapies.

Therapeutic Areas